Cargando…
High throughput development of TCR-mimic antibody that targets survivin-2B(80-88)/HLA-A*A24 and its application in a bispecific T-cell engager
Intracellular tumor-associated antigens are targeted by antibodies known as T-cell receptor mimic antibodies (TCRm-Abs), which recognize T-cell epitopes with better stabilities and higher affinities than T-cell receptors. However, TCRm-Abs have been proven difficult to produce using conventional tec...
Autores principales: | Kurosawa, Nobuyuki, Wakata, Yuka, Ida, Kenta, Midorikawa, Aki, Isobe, Masaharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614450/ https://www.ncbi.nlm.nih.gov/pubmed/31285464 http://dx.doi.org/10.1038/s41598-019-46198-5 |
Ejemplares similares
-
Development of a T‐cell receptor mimic antibody targeting a novel Wilms tumor 1‐derived peptide and analysis of its specificity
por: Kurosawa, Nobuyuki, et al.
Publicado: (2020) -
Development and validation of monoclonal antibodies against N6-methyladenosine for the detection of RNA modifications
por: Matsuzawa, Shun, et al.
Publicado: (2019) -
TCR-mimic bispecific antibodies to target the HIV-1 reservoir
por: Sengupta, Srona, et al.
Publicado: (2022) -
Novel method for the high-throughput production of phosphorylation site-specific monoclonal antibodies
por: Kurosawa, Nobuyuki, et al.
Publicado: (2016) -
TCR mimic compounds for pHLA targeting with high potency modalities in oncology
por: Gerber, Hans-Peter, et al.
Publicado: (2022)